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1. Introduction  
The liver is a highly specialized detoxifying organ involved in: i) glucose homeostasis; ii) 
lipid homeostasis and ketone bodies production; iii) metabolism of amino acids. Most of the 
liver functions are carried out by the hepatocytes (about 70-75% of hepatic cells) that, 
together with cholangiocytes (10-5 % of hepatic cells), are of endodermal derivation and 
constitute the hepatic parenchyma.  
The liver has a peculiar and fascinating ability: it is able to regenerate itself after loss of 
parenchyma for surgical resection or injuries caused by drugs, toxins or acute viral diseases. 
The ancient myth of Prometheus highlighted this capability: the Titan Prometheus was 
bound for ever to a rock as punishment by Zeus for his theft of the fire; each day a great 
eagle ate his liver and each night the liver was regenerated, only to be eaten again the next 
day.  
The liver compensatory regeneration is a rapid and tightly orchestrated phenomenon 
efficiently ensuring the reacquisition of the original tissue mass and its functionality. 
Primarily, it involves the re-entry into cell cycle of parenchymal hepatocytes which are able 
to completely recover the original liver mass (Fausto, 2000). The liver anatomical and 
functional units reconstitution also requires non-parenchymal cells (endothelial cells, 
cholangiocytes, Kupffer cells, stellate cells). It is yet not clear if each cell histotype is 
involved in the proliferative process or if the regeneration requires the activity of a cell with 
multiple differentiation potential. Recently, the bipotentiality of the hepatocytes, able to 
divide giving rise to both hepatocytes and cholangiocytes, has been suggested. Furthermore, 
when injury is severe or the hepatocytes can no longer proliferate a progenitor cell 
population, normally a quiescent compartment is activated. A population of small portal 
cells named oval cells was first identified in 1978 by Shinozuka and colleagues (Shinozuka et 
al., 1978). Now as “oval cells” is indicated a heterogeneous population of bipotent transient 
amplifying cells, originating from the Canal of Hering (Dabeva & Shafritz, 1993). These cells 
are normally quiescent but, after injury, rapidly and extensively proliferate and differentiate 
in hepatocytes and cholangiocytes (Yovchev et al., 2008). 
The observation that oval cells are a mixed precursor population suggests their 
differentiation from liver stem cells (Theise et al., 1999). Since the hepatocytes are able to 
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regenerate themself to compensate liver mass loss, the existence of a liver stem cell, able to 
drive regeneration in conditions of extreme toxicity affecting the same hepatocytes, has long 
been debated. Today, there is growing evidence that the liver stem cell exists and its 
isolation from the organ, its numerical expansion in vitro and its characterization are joint 
efforts in many laboratories around the world. The interest of the scientific community in 
the identification, isolation and manipulation of the hepatic stem cell also depends on the 
fact that the great hopes placed in the use of mature hepatocytes in cell transplantation 
protocols for the treatment of liver diseases have been disappointed. The basis of these 
unsatisfactory therapeutic approaches lie in the paradox, not yet resolved, of the inability of 
hepatocytes, which show in vivo a virtually unlimited proliferative potential, to grow in vitro 
to quantitatively and qualitatively amount suitable for cell transplantation in adults.  
2. Hepatocyte and regeneration 
Regeneration of the original liver mass after damage has been extensively studied in rodents 
after two-thirds partial hepatectomy (PH) (Bucher, 1963). Regeneration of the liver depends 
on both hyperplasia and hypertrophy of the hepatocytes, cells that in a normal adult liver 
exhibit a quiescent phenotype. Hypertrophy begins within hours after PH then hyperplasia 
follows (Taub, 2004). This occurs first in the periportal region of the liver lobule then 
spreads toward the pericentral region (Fausto & Campbell 2003).  
The restoration of liver volume depends on three steps involving the hepatocytes: i) 
initiation, ii) proliferation and iii) termination phases.  
The initiation step depends on the “priming” of parenchymal cells, mainly via the signaling 
pathways triggered by the cytokines IL-6 and TNF-α secreted by Kupffer cells, rendering 
the hepatocytes sensitive to growth factors and competent to replication.  
After the G0/G1 transition in the initiation phase, the hepatocytes will enter into the cell 
cycle (Taub, 2004). Growth factors, primarily HGF, epidermal growth factor (EGF) and TGF-
α, are responsible of this second step of regeneration in which the hepatocytes both 
proliferate and grow in cell size, activating the IL-6/STAT-3 and the PI3K/PDK1/Akt 
pathways respectively. The first signaling cascade regulates the cyclin D1/p21 and also 
protects against cell death, for example by up-regulating FLIP, Bcl2 and Bcl-xL. The latter 
pathway regulates cell size via mammalian target of rapamycin (mTOR) (Fausto, 2000; 
Serandour et al., 2005; Pahlavan et al., 2006; Fujiyoshi & Ozaki 2011). Numerous growth 
factors (for example HGF, TGF-α, EGF, glucagon, insulin and cytokines like TNF, IL-1 and -
6 and somatostatin (SOM)) are implicated in the regeneration process. 
The HGF is a potent growth factor mainly acting on hepatocytes in a paracrine manner 
binding to its specific trans-membrane receptor tyrosine kinase c-met. HGF is secreted as an 
inactive precursor and stored in the extracellular matrix (ECM), then activated by the 
fibrinolytic system (Kim et al., 1997). Plasmin and metalloproteinases (MMPs) degrade the 
ECM and release pro-HGF that, in turn, is cleaved into an activated form by the urokinase-
type plasminogen activator (u-PA)(Kim et al., 1997). The HGF/met signaling is transduced 
to its downstream mediators, i.e. the Ras-Raf-MEK, ERK1/2 (Borowiak et al., 2004), 
PI3K/PDK1/Akt (Okano et al., 2003) and mTOR/S6 kinase pathways, resulting in cell cycle 
progression.  
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TGF- α is another growth factor relevant in liver regeneration (Tomiya et al., 2000). It 
belongs to the EGF family, of which all members (EGF, heparin binding EGF-like factor and 
amphiregulin) transduce trough the common receptor EGF receptor (EGFR) and exert 
overlapping functions (Fausto 2004). This factor acts in autocrine and paracrine fashions and 
its production and secretion are induced by HGF. 
IL-6 induces mitotic signals in hepatocytes through the activation of STAT-3 (Cressman et 
al., 1996). The IL-6/STAT-3 signaling involves several proteins: the IL-6 receptor, gp130, 
receptor-associated Janus kinase (Jak) and STAT-3. The IL-6 receptor is in a complex with 
gp130, which, after recognition by IL-6, transmits the signal. Jak is responsible of gp130 and 
STAT-3 activation after IL-6 binding. The STAT-3 form released by gp130 dimerizes and 
translocates to the nucleus to activate the transcription. STAT3 controls cell cycle 
progression from G1 to S phase regulating the expression of cyclin D1. In fact, in the liver-
specific STAT3-KO model mice, mitotic activity of hepatocytes after PH is reduced 
significantly (Li et al., 2002).  
The PIK/PDK1/Akt signaling pathways are activated by receptor tyrosine kinases or 
receptors coupled with G proteins by IL-6, TNF-α, HGF, EGF, TGF-α and others (Desmots et 
al., 2002) (Koniaris et al., 2003). An important downstream molecule of Akt for cell growth is 
mTOR (Fingar et al., 2002). The activation of this pathway coexists with STAT-3 signaling. In 
STAT-3-KO mice no significant differences were observed macroscopically in liver 
regeneration in comparison to control animals, reaching the liver of these mice after PH an 
equal size. This observation may be explained considering the increase in size of the 
hepatocytes.  Increase in cell size corresponds to marked phosphorylation of Akt and its 
downstream molecules p70 S6K, mTOR and GSK3beta (Haga et al., 2005).  
The third phase in liver regeneration is the termination step. A stop signal is necessary to 
avoid an inappropriate liver functional size but the molecular pathways involved in this 
phenomenon are not yet clear. A key role is exerted by the cytokine TGF-β, secreted by 
hepatocytes and platelets, that inhibits DNA synthesis (Nishikawa et al., 1998). In fact, 
within 2-6 hours after PH, the insulin growth factor (IGF) binding protein-1 (IGFBP-1) is 
produced to counteract its inhibitor effects (Ujike et al., 2000). 
3. Liver progenitor cells and regeneration 
When liver parenchyma damage is particularly serious and hepatocytes are no longer able 
to proliferate, liver regeneration can occur through the intervention of bipotent progenitor 
cells that can proliferate and differentiate into hepatocytes and bile duct cells. It was 1950 
when Wilson and Leduc, studying the regeneration of rat liver after severe nutritional 
damage, observed for the first time these particular cells, located within or immediately 
adjacent to the Canal of Hering, and their differentiation into two histological types of liver 
epithelial cells (Wilson & Leduc, 1950). In 1956 Faber called these cells, which are found in 
the liver of mice treated with carcinogens (Farber 1956), "oval cells" for their morphology. 
The first characterization of oval cells has shown the simultaneous expression of bile ducts 
(CK-7, CK-19 and OV-6) and hepatocytes (alpha-fetoprotein and albumin) markers (Lazaro 
et al., 1998). Subsequent studies have shown the activation, during oval cell compartment 
proliferation, of stem cell genes such as c-kit (Fujio et al., 1994), CD34 (Omori et al., 1997) 
and LIF (Omori et al., 1996) . 
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Stable lines of oval cells, useful for in vitro and in vivo studies of differentiation and of liver 
colonization, were obtained from normal rat liver F-334 (Hixson et al., 1990), or from rats fed 
with DL-ethionine (Sells et al., 1981) or treated with allyl alcohol (Yin et al., 1999). In 
addition, these precursors were stabilized starting from liver explants of animal models of 
Wilson disease (Yasui et al., 1997) of transgenic mice expressing Ras (Braun, et al., 1987) of 
p53 knockout mice fed with choline-free diet and finally of human liver (Dumble et al., 
2002). 
The oval cell is currently the best characterized liver progenitor cell although several studies 
have demonstrated the presence of precursors/stem cells either residing in the liver or 
coming from blood. 
Regardless of the species in which were observed and the name that was given to them, the 
progenitor cells of the liver have common characteristics: 
• they are very few and hardly recognizable in the healthy liver, but clearly evident as a 
result of chronic liver injury near the terminal trait of  biliary duct; 
• they express cholangiocyte and hepatocyte markers; 
• they are basophilic, with a high ratio of nucleus/cytoplasm  and are smaller than 
mature hepatocytes (10 μM in diameter compared to 50 of hepatocytes); 
• they are immature and have a great proliferative capacity.  
Further than oval cells, other bipotential precursor cells able to differentiate and colonize 
diseased liver in animal models have been isolated from rodent and human livers, allowing 
the study of molecular mechanisms triggering their differentiation. The identification and 
characterization of an immortalized bipotent precursor cell was firstly described by 
Spagnoli and coworkers (Spagnoli et al., 1998) in MMH cell lines. MMHs (Met Murine 
Hepatocyte) are immortalized cell lines derived from explants of embryonic, fetal and new-
born livers derived from transgenic mice expressing a constitutively active truncated human 
Met receptor (cyto-Met) (Amicone et al., 1997). All of the MMH lines are not tumorigenic 
and show a differentiated phenotype judging from the retention of epithelial cell polarity 
and the expression of liver enriched transcriptional factors (LETF). In addition, many of 
them express hepatic functions. MMHs have been found to contain a cell subpopulation 
constituted by fibroblastoid cells, called "palmate cells" for their morphology, showing 
characteristics of a bipotent progenitor. The palmate cells are not polarized, do not express 
liver specific transcription factors or liver products, but retain the ability to divide and 
differentiate into hepatocytes and bile duct cells. Unequivocal demonstration that palmate 
cells can give rise to epithelial-hepatocytes is provided by cloning of individually fished 
cells and characterization of their progeny. Moreover, as true stem cells, palmate cells are 
diploid whereas their epithelial progeny is hypotetraploid. All of these findings 
demonstrate that palmate cells are the precursors of hepatocytes in MMH cell lines. These 
bipotential liver cells are also able to in vivo differentiate into hepatocytes and colonize 
diseased livers in mice (Spagnoli et al., 1998). Using the same methods of isolation and 
selection, Strick-Marchand and Weiss subsequently isolated, from mouse embryos wild-
type, bipotent cells able to regenerate livers of mice uPA/SCID mice (Strick-Marchand & 
Weiss 2002). Bipotent progenitors were isolated and stabilized also from pig liver (Strick-
Marchand et al., 2004), monkey (Talbot et al., 1994) and human fetal liver (Allain et al., 
2002).  
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The identification of precursor cells has increasingly strengthened the idea that in the liver 
there are also real stem cells with a wide differentiation potential (capable of explaining 
many processes not yet fully understood such as liver development and regeneration) and 
which may give rise, by asymmetric division, to the same bipotent precursor cells.  
The immunophenotypic characterization of the heterogeneous oval cell population, in 
which there are cells expressing hematopoietic stem cells (HSC) (eg, c-kit, CD34 and Thy-1) 
markers, had initially led to believe that oval cells could originate from the recruitment and 
differentiation of circulating HSC. In fact, many studies have demonstrated the ability of 
HSCs to differentiate into hepatocytes in vitro and their mobilization from the marrow and 
recruitment in the liver during regeneration. Two independent works (Wang et al., 2003; 
Vassilopoulos et al., 2003) however, have shown that stem cells derived from murine bone 
marrow and transplanted in FAH-/- mice, were involved in the regeneration of the 
damaged liver tissue through a process of cell fusion with endogenous hepatocytes rather 
than through a trans-differentiation process. The new hepatocytes in fact had both host and 
donor genetic markers. The events of trans-differentiation of HSC precursors into oval cells 
or hepatocytes documented to date are in fact extremely rare (Menthena et al., 2004; 
Grompe, 2003; Fausto, 2004; Thorgeirsson & Grisham, 2006). Mesenchymal-like cell 
population, depicting high level of proliferation and possessing a broad differentiation 
potential, has been isolated from adult human liver (Herrera et al., 2006; Najimi et al., 2007). 
The efforts of different research groups is still directed towards the identification and 
isolation of a cell "resident" in the liver with stem cell characteristics, namely the ability to 
regenerate itself (self-renewal) and, more importantly, to divide asymmetrically, generating 
a cell identical to itself and a bipotent progenitor. 
Reid and colleagues focused on human hepatic stem cells and highlighted as liver is 
comprised of different maturational lineages of cells both intrahepatically in periportal zone 
by the portal triads and  extrahepatically in the hepato-pancreatic common duct (Turner et 
al., 2011 ). More in dectail, the intrahepatic stem cell niches have been located  in  the canals 
of Hering  ( for  pediatric and adult livers)  and in the  ductal plates  ( for fetal and neonatal 
livers) (Schmelzer et al., 2007; Turner et al., 2011; Zhou et al., 2007). The  extrahepatic niche 
was recently unveiled by the Reid’s research group that demonstrated the presence of 
multipotent stem/progenitors in human peribiliary glands, deep within the duct walls, of 
the extrahepatic biliary trees (Cardinale et al., 2011 and 2012). These cells, which self-
replicate, are positive for transcriptional factors typical of endoderm and surface markers 
typical of stem/progenitors and may express genes of liver, bile duct and pancreatic 
genes.  
Conigliaro and colleagues recently reported the identification, the isolation from fetal and 
neonatal murine livers, the characterization and the reproducible establishment in line of a 
non-tumorigenic “liver resident stem cell” (RLSC), that proved to be a useful tool to study 
liver stem cell biology (Conigliaro et al., 2008). The immunophenotype of this cell (CD34- 
and CD45-) indicates a not hematopoietic origin and the transcriptional profile highlights 
the expression of a broad spectrum of ‘plasticity-related genes’ and ‘developmental genes’, 
indicating a multi-differentiation potential. Indeed, RLSCs not only differentiate 
spontaneously into hepatocytes and cholangiocytes (suggesting their partial endodermal 
determination), but can be induced in vitro to differentiate into osteocytes, chondrocytes and 
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cells of neuroectodermal derivation (astrocytes, neurons). The ability of RLSCs to 
differentiate spontaneously in hepatocytes, the lack of albumin and the wide differentiation 
potential place these liver stem cells at the pre-hepatoblast/liver precursor hierarchical 
position. Notably, RLSCs are also a model to in vitro study liver zonation. This term 
indicates the typical distribution into hepatic lobule of several functions. Most of the main 
metabolisms of the liver, in fact, are not uniformly distributed over the hepatic lobule but 
follow gradients of enzymatic activities along the centrolobular/portal axis. Coherently, 
adult hepatocytes undergo into a post-differentiation patterning resulting into a zonal 
heterogeneity of gene expression and functions defined “metabolic zonation”. Specific 
enzymatic/metabolic activities, i.e. carbohydrate metabolism, ammonia detoxification, bile 
formation/transport/secretion and drug biotransformation, are confined to the perivenular 
(PV, i.e. near the centrolobular vein) or periportal (PP, i.e. near the portal vein) zones of the 
hepatic lobule (Gebhardt, 1992). The elucidation of the mechanisms responsible for 
induction and maintenance of the hepatocyte heterogeneity remains one of challenge in 
experimental hepatology. Intriguingly, inversion of the blood flow direction changes the 
enzymatic gradients and, consequently, the zonation of some, but not all, the liver 
metabolisms, thus revealing the influence exerted by the oxygen and circulating molecules 
on this phenomenon (Kinugasa  & Thurman, 1986). For the bloodstream independent 
gradients, cell-cell and cell-extracellular matrix interactions and paracrine signaling have 
been suggested as instructive stimuli (Gebhardt & Reichen, 1994).  Recently, concerning 
soluble factors, a key role of the Wnt/ǃ-catenin pathway has been unveiled. Within the 
hepatic lobuli, Wnt signaling has been proposed to originate from endothelial cells of the 
central vein and follows a stable gradient that decrease toward the PV–PP axis.  In the liver, 
Benhamouche and collaborators observed a mutually exclusive localization of activated ǃ-
catenin and its negative regulator APC in the PV and in PP hepatocytes, respectively. 
Moreover, these authors demonstrated that genetic manipulation of APC expression and 
adenoviral delivery of the extracellular antagonist of Wnts DKK allowed to switch the 
phenotype from PP into PV and vice versa (Benhamouche et al., 2006). 
A second key element in controlling hepatic zonation was identified in the transcriptional 
factor HNF4ǂ: Stanulovic and colleagues have recently shown that this orphan nuclear 
receptor regulates the zonal expression of some genes, including Cyp7, UDP-
glucuronyltransferase and apolipoprotein E (Stanulovic et al., 2007). Their analysis of 
HNF4ǂ knock-out mice revealed in PV hepatocytes a maintenance of PV genes expression 
and in PP hepatocytes the inhibition of a PP gene (PEPCK) coupled to the activation of PV 
genes. These observations led to the conclusion that HNF4ǂ exerts a dual role of activator of 
PP genes and inhibitor of PV genes in PP hepatocytes. In frame with these observations 
Colletti and colleagues showed as RLSCs spontaneously differentiate into periportal 
hepatocytes that, following Wnt pathway activation, switch into perivenular hepatocytes. 
Moreover, they gathered evidences showing a direct convergence of the canonical Wnt 
signaling pathway and HNF4ǂ in controlling the hepatocyte heterogeneity. HNF4ǂ and Wnt 
signaling pathway have been proposed as active members of the same machinery that controls 
the transcription of differentially zonated HNF4–dependent genes (Colletti et al., 2009). 
In conclusion we can say that there are no more doubts about the existence of liver stem 
cells residing in the liver although there is still much to do especially with regard to the 
identification and characterization of specific microenvironments able to define the 
corresponding tissue stem- niche. 
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4. Molecular mechanisms controlling liver stem cell fate  
A stem cell “niche” is believed to maintain the liver progenitor cells in a native state and 
allows their activation when required. It is conceived as a restricted area in an adult organ 
that regulates, by means of micro-environmental signaling, stem cell maintenance and 
differentiation.  Stem cell behavior, in particular the balance between self-renewal and 
differentiation, is ultimately controlled by the integration of autocrine and paracrine factors 
supplied by the surrounding microenvironment. Stem cells respond to these instructive 
signals from the niche by changing their expression profile in a reversible manner. In 
particular, instructive signals received from the niche influence the so-called stem cell 
“metastable” phenotype.  The metastability, currently considered a common characteristic 
of embryonic and adult stem cells and a manifestation of cell plasticity (McConnell 
&Kaznowski, 1991; Hay, 1995; Thomson et al., 1998; Blau et al., 2001; Burdon et al., 2002; 
Reddy et al., 2002; Prindull & Zipori, 2004), consists essentially in the cell capability to 
change the expression profile in a reversible manner and it is characterized by the co-
expression of  both epithelial and mesenchymal traits. This highly dynamic cell state may be 
considered as a balance between epithelial-mesenchymal and mesenchymal-epithelial 
transitions (EMT/MET). Both the EMT and the reverse process MET are typical events of 
development, tissue repair and tumor progression. The EMT is the process by which 
polarized cells, closely attached to each other, gradually lose epithelial features and acquire 
mesenchymal characteristics, including invasiveness and motility (Thiery et al., 2009). MET 
refers to the reverse phenomenon often occurring in a secondary site, by which the epithelia-
derived mesenchymal cells reacquire their epithelial phenotype. 
The observation that a number of stem cells are restricted to a specific differentiation fate 
suggests that elements pivotal for their metastability and for the coordinated execution of 
opposite processes, such as self-renewal and differentiation, may be tissue specific. A simple 
and direct molecular mini-circuitry of master elements of mutually exclusive biological 
processes, able also to reciprocally influence their own expression, may provide the best 
device to trigger such complex phenomena.  
The availability of a stable stem cell line executing specific differentiation programs 
discloses a unique possibility to investigate mechanisms regulating alternative cellular 
choices. 
Recently, RLSCs and hepatocytes derived from their differentiation (RLSCdH) permitted to 
identify a simple cross-regulatory circuitry between HNF4ǂ (master regulator of hepatocyte 
differentiation and MET inducer) and Snail (master regulator of the EMT), whose expression 
is mutually exclusive due to their direct reciprocal transcriptional repression (Cicchini et al., 
2006; Santangelo et al., 2011). In particular, Cicchini and co-workers showed that Snail 
represses the HNF4ǂ transcription through the direct binding to its promoter (Cicchini et al., 
2006) and that  Snail over-expression is sufficient i) to induce EMT in hepatocytes with 
change of morphology, down-regulation of several epithelial adhesion molecules, reduction 
of proliferation and induction of matrix metalloproteinase 2 expression and, ii) most 
relevantly, to directly repress the transcription of the HNF4α gene. These findings 
demonstrated that Snail is at the crossroads of the regulation of EMT in hepatocytes by a 
dual control of epithelial morphogenesis and differentiation. More recently, Santangelo and 
colleagues collected evidence that HNF4ǂ  has a direct master role in the MET process of the 
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hepatocyte and that its differentiation role is intrinsically linked to an active repression of 
mesenchymal program expression (Santangelo et al., 2011). Their data highlight as both, key 
EMT regulators (Snail and Slug) and mesenchymal genes, have to be included among the 
target genes relevant for HNF4ǂ1 master function in controlling epithelial phenotype. Their 
main finding was to ascribe to HNF4ǂ1 a general “anti-EMT” role through the orchestrated 
repression of both master EMT regulators and mesenchymal markers. HNF4ǂ-mediated 
repression of mesenchymal gene program, moreover, is executed not only in the dynamic 
EMT/MET processes but also in the stable maintenance of the hepatocyte epithelial 
phenotype.  In fact, they found that: in dedifferentiated hepatomas HNF4ǂ1 ectopic 
expression was sufficient to down-regulate Snail, Slug, HMGA2, Vimentin and Fibronectin 
genes.  In addition, in differentiated hepatocytes, HNF4ǂ1 was found stably recruited to the 
promoters of EMT inducers and its knockdown caused the upregulation of these genes.   
Consistent with these observations Garibaldi and colleagues (Garibaldi et al., 2011)Garibaldi 
et al., in press demonstrated that the same molecular players in an epistatic mini-circuitry 
are pivotal for the RLSC maintenance. In particular they observed that hepatic stem cells 
constitutively express Snail and that their spontaneous differentiation into hepatocytes is 
underlined by negative regulation of Snail expression.  Snail silencing causes down-
regulation of stemness markers and its ectopic expression in hepatocytes is sufficient to 
restore their expression. In RLSC Snail stably represses HNF4 and miR-200a-b-c and miR-
34a, known as stemness inhibiting microRNAs and distinctive of epithelial cells. This latter 
activity is probably due to a direct mechanism as suggested by the binding of endogenous 
Snail to miR-200c and 34a promoters in RLSC. In terms of conceptual advances, these data 
allow to extend the role of Snail from EMT inducer to stemness stabilizer. 
In the light of the previously demonstrated reciprocal repression between Snail and HNF4ǂ 
these observations have been extended: Garibaldi and colleagues described that HNF4α is 
required for miR-200a-b-c, and miR-34a expression in hepatocytes and that HNF4α silencing 
in hepatocytes and its targeting in KO mouse models correlates with a strong down-
regulation of their expression. This is probably due to a direct mechanism as suggested by 
the fact that endogenous HNF4α was found recruited on miR-200a-b, miR-200c and miR-34a 
promoters in both differentiated hepatocytes and mouse liver. Notably, in HNF4 KO mouse 
models miRs down-regulation correlates to a strong up-regulation of the stemness markers 
SCA1 and FOXA1. Thus HNF4α, first identified as a positive regulator of hepatocyte 
differentiation and recently located at the crossroad of other cellular functional categories 
(i.e. cell cycle, apoptosis, stress response) appears to participate also in the active repression 
of stemness.  
The proposed mechanism implies that the execution of a stemness program requires the 
active repression of a differentiation program while the maintenance of the hepatocyte one 
requires the active repression of stemness traits. These observations, focusing on epithelial 
differentiation, are centered on a HNF4α/Snail/epithelial-miRs circuitry, however may be 
conceivable that other differentiation pathways could be regulated by similar mechanisms. 
In this light Snail can probably be considered as a general factor counteracting (and 
counteracted by) tissue-specific regulators. This is further suggested by studies indicating 
that Snail family members repress the expression of tissue-specific inducers as the pro-
neural genes sim and rho (Xu et al., 2010) and the skeletal muscle master regulator MyoD 
(Kosman et al., 1991). 
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5. Hepatocyte transplantation in cell-based therapeutic 
Animal models in which transplanted cells show a selective advantage over resident 
hepatocytes have been used to study transplantation, proliferation and reconstitution 
potential of the hepatocytes. Liver animal models belong to three groups (Palmes & Spiegel 
2004): i) hepatotoxin-induced models; ii) surgical models; iii) animal models of hereditary 
liver defects.   
Normal adult hepatocytes can be serially transplanted and single hepatocyte can be clonally 
amplified, showing stem-like properties, and serially passaged to repopulate almost 70% of 
the liver of (Fah)-deficient mice (Overturf et al., 1999). Excellent results have been obtained 
by using transgenic Rag2-/-/Il2rg-/- mice (deficient for the recombinant activation gene-2 and 
the common γ-chain of the interleukin receptor) (Traggiai et al., 2004) or the Alb-uPA(tg(+/-) 
mice (expressing the uroplasminogen activator (uPA) under the transcriptional control of 
the albumin promoter) (Sandgren et al., 1991)) or mice obtained by the crossing of the above 
reported genotypes (Haridass et al., 2009; Azuma et al., 2007). 
Hepatocyte transplantation protocols in humans have been proposed as an alternative to 
orthotropic liver transplantation in patients and used for some metabolic disorders i.e. 
familial hypercholesterolemia, glycogen storage disease type 1a, urea cycle defects and 
congenital deficiency of coagulation factors (Quaglia et al., 2008). Currently, the liver 
transplantation is the treatment of choice for acute and chronic end-stage liver failure and 
for diseases refractory to other treatments; but the limited availability of donor organs is the 
major limiting factor in this therapeutic procedure. Although different techniques of 
implants using either complete liver, liver reduced or hyper-reduced "split liver" (liver for 
two) have tried to overcome the shortage of organs, liver transplantation remain an 
unsufficient approach to satisfy the needs of patients with liver disease. 
In recent years, hepatocyte transplantation has emerged as a potential alternative or 
complementary procedure to liver transplantation, at least in certain circumstances. The 
application of this therapeutic modality is based on the concept that cell transplantation 
would replace the function of the affected organ, either temporarily, allowing the recovery 
of the organ functionality or the availability of a liver for the transplant, or permanently, 
preventing need for this last procedure. 
The development of this therapeutic approach could provide a new opportunity for patients 
with liver disease, particularly for children suffering from some metabolic diseases, with 
certain advantages over liver transplantation. In fact it is a less invasive and risky procedure 
and it has a lower cost. There is also a greater availability of material to be transplanted and 
that could be used as a source of cells (organs considered "marginal", material resulting 
from organ reductions, from partial hepatectomy and cadaveric livers unsuitable for 
transplantation) and the possibility of using a donor to several recipients.  
Despite these advantages, a number of critical issues are still unresolved: the rejection of 
transplanted hepatocytes, their correct localization and functionality and, mostly, cells 
availability at the right time. The latter remains a problem that would be definitively solved 
with the cultivation and the preservation of large scale culture of hepatocytes. Nevertheless, 
these cells in culture, contrary to what happens in vivo during liver regeneration, have a 
very low proliferative potential and quickly lose their differentiated characteristics. 
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This implies that cell therapy can be carried out only with freshly isolated cells, not 
expanded in vitro. The number of cells that can be achieved with this approach is usually not 
sufficient to colonize adult livers, while there is more chance of success in pediatric patients 
with metabolic diseases of genetic origin since they can be treated with a limited number of 
hepatocytes. 
6. Conclusion 
Liver stem cells may represent an important tool for the treatment of the liver diseases. They 
could be an alternative source of functional hepatocytes aimed at cell transplantation, tissue 
engineering and bio-artificial liver. Manipulation of stem cells will be more efficient since 
we know the factors controlling their biology. Only by dissecting the molecular events 
underlying the stemness, the differentiation choice and the maintenance of the differentiated 
phenotype can we control stem cell behavior for therapeutic purposes. The translation of in 
vitro studies in in vivo experimental models and, finally, in humans is one of the major 
challenges of experimental hepatology. Moreover, better understanding the mechanisms 
that control the proliferation of stem and progenitor cells will shed new light on the 
molecular and cellular basis of liver cancer. 
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